Physician profile
Kyle Kramer
NPI 1437808300
$1,757.49
in general payments reported to CMS, 2019-2025
15 companies · $969 in 2025
The $969 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $44.12 · 2023: $192 · 2024: $553 · 2025: $969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,713.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $335.50 | 2023-2024 | Senza |
| Boston Scientific Corporation | $226.42 | 2022-2025 | Intracept, General - Pain Management, Varithena Administration Pack |
| Pfizer INC. | $202.69 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $188.98 | 2023-2025 | Belbuca, Xtampza |
| Globus Medical, INC. | $182.51 | 2025 | Senza |
| Stryker Corporation | $158.32 | 2025 | Mild Device Kit |
| Abbott Laboratories | $157.97 | 2025 | Proclaim |
| Abbvie INC. | $91.37 | 2023-2025 | |
| Mml US, INC. | $60.80 | 2025 | Reactiv8 |
| Spr Therapeutics, INC | $41.58 | 2025 | Sprint Pns System |
| Tonix Medicines, INC. | $33.19 | 2025 | Tonmya |
| Biohaven Pharmaceutical Holding Company LTD. | $26.53 | 2022 | |
| Impel Pharmaceuticals INC. | $19.06 | 2023 | Trudhesa |
| Medtronic, INC. | $18.88 | 2025 | Inceptiv |
| Vertex Pharmaceuticals Incorporated | $13.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.